Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices 70197 

Dated: November 19, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–27821 Filed 11–24–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Cures 

Acceleration Network Review Board. 

The meeting will be open to the public, 

viewing virtually by WebEx. Individuals 

can register to view and access the 

meeting by the link below. https:// 

ncatsevents.webex.com/ncatsevents/

onstage/g.php?MTID=eb948880d82d

5d6f0c3d3b5ad5cd7429e. 

1. Go to ‘‘Event Status’’ on the left 

hand side of page, then click ‘‘Register’’. 

On the registration form, enter your 

information and then click ‘‘Submit’’ to 

complete the required registration. 

2. You will receive a personalized 

email with the live event link. 

Name of Committee: Cures Acceleration 

Network Review Board. 

Date: December 12, 2014. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: The CAN Review Board will meet 

virtually to discuss updates regarding CAN 

programs and next steps. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Danilo A. Tagle, Ph.D., 

Executive Secretary, National Center for 

Advancing Translational, Sciences, 1 

Democracy Plaza, Room 992, Bethesda, MD 

20892, 301–594–8064, Danilo.Tagle@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to finalizing 

the agenda and scheduling of meeting topics. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Dated: November 19, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–27819 Filed 11–24–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Recombinant DNA Advisory Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Recombinant DNA 

Advisory Committee. 

Date: December 11, 2014. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: The NIH Recombinant DNA 

Advisory Committee (RAC) will review and 

discuss selected human gene transfer 

protocols and related data management 

activities. Please check the meeting agenda at 

OBA Meetings Page (available at the 

following URL: http://oba.od.nih.gov/rdna_

rac/rac_meetings.html) for more information. 

Place: National Institutes of Health 

Building 45, Conference Room, E1/E2 9000, 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Chris Nice, Program 

Assistant, Office of Biotechnology Activities, 

National Institutes of Health, 6705 Rockledge 

Drive, Suite 750, Bethesda, MD 20892, 301– 

496–9838, nicelc@mail.nih.gov 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

oba.od.nih.gov/rdna/rdna.html, where an 

agenda and any additional information for 

the meeting will be posted when available. 

OMB’s ‘‘Mandatory Information 

Requirements for Federal Assistance Program 

Announcements’’ (45 FR 39592, June 11, 

1980) requires a statement concerning the 

official government programs contained in 

the Catalog of Federal Domestic Assistance. 

Normally NIH lists in its announcements the 

number and title of affected individual 

programs for the guidance of the public. 

Because the guidance in this notice covers 

virtually every NIH and Federal research 

program in which DNA recombinant 

molecule techniques could be used, it has 

been determined not to be cost effective or 

in the public interest to attempt to list these 

programs. Such a list would likely require 

several additional pages. In addition, NIH 

could not be certain that every Federal 

program would be included as many Federal 

agencies, as well as private organizations, 

both national and international, have elected 

to follow the NIH Guidelines. In lieu of the 

individual program listing, NIH invites 

readers to direct questions to the information 

address above about whether individual 

programs listed in the Catalog of Federal 

Domestic Assistance are affected. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.14, 

Intramural Research Training Award; 

93.22, Clinical Research Loan 

Repayment Program for Individuals 

from Disadvantaged Backgrounds; 

93.232, Loan Repayment Program for 

Research Generally; 93.39, Academic 

Research Enhancement Award; 93.936, 

NIH Acquired Immunodeficiency 

Syndrome Research Loan Repayment 

Program; 93.187, Undergraduate 

Scholarship Program for Individuals 

from Disadvantaged Backgrounds, 

National Institutes of Health, HHS) 

Dated: November 19, 2014. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–27822 Filed 11–24–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No DHS–2014–0066] 

Homeland Security Advisory Council— 

New Tasking 

AGENCY: The Office of Policy, DHS. 

ACTION: Notice of task assignment for the 

Homeland Security Advisory Council. 

SUMMARY: The Secretary of the 

Department of Homeland Security 

(DHS), Jeh Johnson tasked his 

Homeland Security Advisory Council 

(HSAC) to establish a subcommittee 

entitled the DHS Grant Review Task 

Force on Friday November 7, 2014. The 

DHS Grant Review Task Force will 

provide recommendations to the 

Homeland Security Advisory Council 

on how to improve the allocation of 

annual grant funds among jurisdictions. 

This notice informs the public of the 

establishment of the DHS Grant Review 

Task Force and is not a solicitation for 

membership. 

FOR FURTHER INFORMATION CONTACT: 

Mike Miron, Director, Homeland 

Security Advisory Council and the DHS 

Grant Review Task Force at 202–447– 

3135 or mike.miron@dhs.gov. 


wreier-aviles on DSK4TPTVN1PROD with NOTICES